Information about prescription medications is available only for the healthcare professionals!
Are you a healthcare professional?
The story of the first oncolytic virus approved Read More
Virotherapy is an effective cancer treatment that uses oncotropic and oncolytic virus with the ability of a virus to find and destroy malignant cells in the body
Grant competition for publications on clinical studies of oncolytic virotherapy, observations or clinical cases
Virotherapy is gentle and safe treatment, it improves survival and quality of life of patients
Every cancer patient has his story to tell. Here are some of them shared by our patents
Our support agents are here to answer your questions at any time. You can either e-mail us or leave your query on the website and we will contact you.
Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir.
Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.
A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®
Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE
© 2019 International Virotherapy Center Limited. All Rights Reserved
Ltd State of Well (Reg.Nr. 40203172199) on a base of Licence and Cooperation Agreement (No. IVC-SW-02.01.2019), signed January 2nd, 2019 is legally responsible for the content of the website www.virotherapy.eu